TNYA Tenaya Therapeutics, Inc. - Common Stock
$0,80
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 6, 2026
Zakres 52 tyg.
$0–$2
21% of range
Ocena Analityków
BUY
14 analysts
Cena Docelowa
$4
+402% upside
P/E (TTM)
-1.2
ROE
-81.2%
Marża Zysku Netto
—
TNYA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$0.80
Kapitalizacja Rynkowa
$154M
P/E (TTM)
-1.2
EPS (TTM)
$-0.59
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-81.2%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$0 – $2
TNYA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
EPS
$-0.59
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-69M
2021-12-31
→
2025-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
TNYA
Mediana porównawcza
P/E (TTM)
-1.2
—
P/B
1.3
2.2
Price / FCF (Cena / FCF)
-2.2
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
TNYA
Mediana porównawcza
ROA
-67.9%
-58.1%
ROE
-81.2%
-170.7%
ROIC
-75.7%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
TNYA
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
6.8
4.7
Quick Ratio (Wskaźnik Szybkości)
6.5
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
TNYA
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
TNYA
Mediana porównawcza
TNYA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
14 analityków
- Mocne kupno 4 28,6%
- Kup 9 64,3%
- Trzymaj 1 7,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
6 analityków · 2026-05-18
Mediana
$3.50
Średnia
$4.00
← Poniżej wszystkich celów
$0.80
Niski
$2.00
Wysoki
$8.00
Średni cel
$3.50
+338,9%
Średnia cel
$4.00
+401,6%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.02%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.09 | $-0.09 | -0.00% |
| 31 grudnia 2025 | $-0.12 | $-0.12 | 0.00% |
| 30 września 2025 | $-0.12 | $-0.15 | 0.03% |
| 30 czerwca 2025 | $-0.14 | $-0.26 | 0.12% |
| 31 marca 2025 | $-0.24 | $-0.19 | -0.05% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| TNYA | $154M | -1.2 | — | — | -81.2% | — |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
| KPTI | $135M | -0.4 | 0.57% | -134.2% | 73.7% | — |
| ABOS | $128M | -1.1 | — | — | -129.4% | — |
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | — |
| HURA | — | -1.2 | — | — | — | — |
| IMUX | — | -0.9 | — | — | — | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $69M | $87M | $98M | $95M | $54M | $31M | |
| SG&A Expense | $25M | $29M | $33M | $31M | $18M | $8M | |
| Operating Expenses | $93M | $116M | $131M | $126M | $73M | $39M | |
| Operating Income | $-93M | $-116M | $-131M | $-126M | $-73M | $-39M | |
| Interest Income | $3M | $5M | $7M | $2M | $108.0K | $87.0K | |
| Other Non-op | $52.0K | $82.0K | $53.0K | $2.0K | $-23.0K | $355.0K | |
| Pretax Income | $-91M | $-111M | $-124M | $-124M | $-73M | $-38M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-91M | $-111M | $-124M | $-124M | $-73M | $-38M | |
| EPS (Basic) | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 | · | |
| EPS (Diluted) | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 | · | |
| Shares (Basic) | 152,971,259 | 84,822,468 | 73,786,126 | 44,823,597 | 17,734,166 | · | |
| Shares (Diluted) | 152,971,259 | 84,822,468 | 73,786,126 | 44,823,597 | 17,734,166 | · | |
| EBITDA | $-85M | $-107M | $-123M | $-119M | $-70M | · |
Bilans 23
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $101M | $4M | $46M | $95M | $38M | $129M | |
| Short-term Investments | · | $57M | $59M | $91M | $213M | · | |
| Prepaid Expense | $5M | $6M | $7M | $7M | $4M | $1M | |
| Other Current Assets | $1M | $842.0K | $1M | $938.0K | · | · | |
| Current Assets | $106M | $67M | $112M | $194M | $255M | $130M | |
| PP&E (Net) | $28M | $36M | $43M | $51M | $43M | $17M | |
| PP&E (Gross) | $68M | $68M | $68M | $67M | $52M | $24M | |
| Accum. Depreciation | $40M | $32M | $24M | $16M | $9M | $7M | |
| Other Non-current Assets | $4M | $5M | $6M | $5M | $4M | $465.0K | |
| Total Assets | $147M | $120M | $171M | $279M | $314M | $148M | |
| Accounts Payable | $4M | $5M | $6M | $10M | $11M | $1M | |
| Accrued Liabilities | $9M | $8M | $13M | $11M | $9M | $3M | |
| Current Liabilities | $15M | $16M | $23M | $24M | $22M | $5M | |
| Capital Leases | $8M | $11M | $8M | $11M | $14M | · | |
| Other Non-current Liabilities | $410.0K | $281.0K | $253.0K | $228.0K | $182.0K | $19.0K | |
| Total Liabilities | $24M | $27M | $31M | $36M | $36M | $9M | |
| Common Stock | $21.0K | $8.0K | $7.0K | $7.0K | $4.0K | · | |
| Paid-in Capital | $728M | $607M | $543M | $523M | $434M | $2M | |
| Retained Earnings | $-605M | $-514M | $-403M | $-279M | $-156M | $-83M | |
| AOCI | $0 | $28.0K | $-106.0K | $-378.0K | $-141.0K | · | |
| Stockholders' Equity | $123M | $93M | $139M | $243M | $279M | $-81M | |
| Liabilities + Equity | $147M | $120M | $171M | $279M | $314M | $148M | |
| Shares Outstanding | 216,760,283 | 86,542,340 | 68,330,342 | 66,857,113 | 41,291,374 | 1,210,306 |
Przepływy pieniężne 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $9M | $6M | $3M | $2M | |
| Stock-based Comp | $13M | $17M | $15M | $11M | $3M | $741.0K | |
| Other Non-cash | $851.0K | $-4M | $-2M | $1M | $6M | · | |
| Operating Cash Flow | $-68M | $-91M | $-102M | $-104M | $-61M | $-35M | |
| CapEx | $618.0K | $1M | $1M | $21M | $25M | $10M | |
| Investing Cash Flow | $56M | $1M | $49M | $84M | $-239M | $-7M | |
| Stock Issued | · | · | $4M | · | · | · | |
| Stock Repurchased | · | · | · | · | $13.0K | $1.0K | |
| Net Stock Activity | · | · | $4M | · | $-13.0K | · | |
| Financing Cash Flow | $108M | $48M | $4M | $78M | $209M | $147M | |
| Net Change in Cash | $96M | $-42M | $-49M | $57M | $-90M | $105M | |
| Taxes Paid | $0 | · | · | · | · | · | |
| Free Cash Flow | $-69M | $-92M | $-103M | $-125M | $-86M | · |
Rentowność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -67.9% | -76.5% | -55.2% | -41.7% | -31.5% | · | |
| ROE | -81.2% | -108.2% | -81.5% | -56.2% | -25.0% | · | |
| ROIC | -75.7% | -124.9% | -94.1% | -51.6% | -26.1% | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 6.8 | 4.2 | 4.9 | 8.0 | 11.7 | · | |
| Quick Ratio | 6.5 | 3.8 | 4.6 | 7.7 | 11.5 | · |
Wycena (TTM) 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-91M | $-111M | $-124M | $-124M | $-73M | · | |
| Market Cap | $154M | $124M | $221M | $134M | $782M | · | |
| P/E | -1.2 | -1.1 | -1.9 | -0.7 | -4.6 | · | |
| P/B | 1.3 | 1.3 | 1.6 | 0.6 | 2.8 | · | |
| P / Tangible Book | 1.3 | 1.3 | 1.6 | 0.6 | 2.8 | · | |
| P / Cash Flow | -2.3 | -1.4 | -2.2 | -1.3 | -12.9 | · | |
| P / FCF | -2.2 | -1.4 | -2.1 | -1.1 | -9.1 | · | |
| Earnings Yield | -82.9% | -91.6% | -51.8% | -137.3% | -21.6% | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $225.0K | · | · | · | $0 | |
| R&D Expense | $15M | $15M | $15M | $17M | $21M | |
| SG&A Expense | $5M | $6M | $6M | $7M | $6M | |
| Operating Expenses | $20M | $21M | $21M | $24M | $28M | |
| Operating Income | $-20M | $-21M | $-21M | $-24M | $-28M | |
| Interest Income | $793.0K | $574.0K | $658.0K | $815.0K | $635.0K | |
| Other Non-op | · | $26.0K | $3.0K | $-16.0K | $39.0K | |
| Pretax Income | $-19M | $-20M | $-20M | $-23M | $-27M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-19M | $-20M | $-20M | $-23M | $-27M | |
| EPS (Basic) | $-0.09 | $-0.09 | $-0.12 | $-0.14 | $-0.24 | |
| EPS (Diluted) | $-0.09 | $-0.09 | $-0.12 | $-0.14 | $-0.24 | |
| Shares (Basic) | 216,883,164 | -283,035,570 | 163,345,972 | 162,791,579 | 109,869,278 | |
| Shares (Diluted) | 216,883,164 | -283,035,570 | 163,345,972 | 162,791,579 | 109,869,278 | |
| EBITDA | $-18M | · | $-21M | $-24M | $-25M |
Bilans 24
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $81M | $101M | $56M | $63M | $54M | |
| Short-term Investments | · | · | · | $9M | $34M | |
| Receivables | $11M | · | · | · | · | |
| Prepaid Expense | $5M | $5M | $5M | $4M | $6M | |
| Other Current Assets | $25.0K | $1M | $990.0K | $218.0K | $1M | |
| Current Assets | $97M | $106M | $61M | $76M | $94M | |
| PP&E (Net) | $26M | $28M | $29M | $31M | $33M | |
| PP&E (Gross) | $68M | $68M | $68M | $68M | $68M | |
| Accum. Depreciation | $42M | $40M | $39M | $37M | $35M | |
| Other Non-current Assets | $4M | $4M | $4M | $4M | $5M | |
| Total Assets | $135M | $147M | $105M | $122M | $144M | |
| Accounts Payable | $2M | $4M | $3M | $3M | $5M | |
| Accrued Liabilities | $6M | $9M | $7M | $7M | $6M | |
| Current Liabilities | $17M | $15M | $13M | $13M | $14M | |
| Capital Leases | $7M | $8M | $9M | $9M | $10M | |
| Other Non-current Liabilities | $418.0K | $410.0K | $301.0K | $293.0K | $287.0K | |
| Total Liabilities | $29M | $24M | $22M | $22M | $25M | |
| Common Stock | $21.0K | $21.0K | $16.0K | $16.0K | $16.0K | |
| Paid-in Capital | $730M | $728M | $668M | $664M | $661M | |
| Retained Earnings | $-624M | $-605M | $-585M | $-565M | $-541M | |
| AOCI | · | $0 | · | $-1.0K | $-10.0K | |
| Stockholders' Equity | $106M | $123M | $83M | $100M | $119M | |
| Liabilities + Equity | $135M | $147M | $105M | $122M | $144M | |
| Shares Outstanding | 216,998,876 | 216,760,283 | · | · | · |
Przepływy pieniężne 9
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $3M | |
| Stock-based Comp | $2M | $3M | $3M | $4M | $4M | |
| Other Non-cash | $-4M | · | · | · | $-3M | |
| Operating Cash Flow | $-19M | $-14M | $-16M | $-16M | $-23M | |
| CapEx | $11.0K | $67.0K | $26.0K | $142.0K | $383.0K | |
| Investing Cash Flow | $-11.0K | $-67.0K | $9M | $25M | $22M | |
| Financing Cash Flow | $-415.0K | $58M | $380.0K | $-476.0K | $50M | |
| Net Change in Cash | $-20M | $44M | $-6M | $9M | $49M | |
| Free Cash Flow | $-19M | · | · | · | $-23M |
Rentowność 7
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating Margin | -8917.8% | · | · | · | · | |
| Net Margin | -8565.3% | · | · | · | · | |
| Pretax Margin | -8565.3% | · | · | · | · | |
| EBITDA Margin | -8134.2% | · | · | · | · | |
| ROA | -13.8% | · | -16.5% | -16.3% | -16.3% | |
| ROE | -17.1% | · | -20.7% | -19.9% | -19.4% | |
| ROIC | -18.9% | · | · | · | -23.1% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.8 | · | 4.6 | 6.0 | 6.7 | |
| Quick Ratio | 5.5 | · | 4.3 | 5.7 | 6.2 |
Efektywność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | |
| Receivables Turnover | 0.0 | · | · | · | · |
Wycena (TTM) 8
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-90M | · | $-96M | $-105M | $-114M | |
| Market Cap | $150M | · | · | · | · | |
| P/E | -1.2 | · | -2.0 | -0.6 | -0.4 | |
| P/B | 1.4 | · | · | · | · | |
| P / Tangible Book | 1.4 | · | · | · | · | |
| P / Cash Flow | -7.8 | · | · | · | · | |
| P / FCF | -7.8 | · | · | · | · | |
| Earnings Yield | -85.3% | · | -49.4% | -166.9% | -224.6% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Zysk netto | $-91M | $-111M | $-124M | $-124M | $-73M |
| Rozwodniony EPS | $-0.59 | $-1.31 | $-1.68 | $-2.76 | $-4.10 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 6.8 | 4.2 | 4.9 | 8.0 | 11.7 |
| Wskaźnik Szybkości | 6.5 | 3.8 | 4.6 | 7.7 | 11.5 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-69M | $-92M | $-103M | $-125M | $-86M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.